Thyroid gland
Bethesda guidelines for Cytology
Atypia of undetermined significance

Author: Phillip A. Williams M.D., MSC, Shahidul Islam M.D., Ph.D., FRCPC (see Authors page)

Revised: 16 January 2017, last major update May 2014

Copyright: (c) 2014-2017, PathologyOutlines.com, Inc.

PubMed Search: Bethesda guidelines atypia
Cite this page: Atypia of undetermined significance. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/thyroidatypia.html. Accessed October 23rd, 2017.
Definition / general
  • Reported in 3 - 18% of thyroid FNAs (very variable and likely overused), but recommended rate is ~7% according to 2009 Bethesda Guidelines
  • Use if: follicle cells, lymphoid or other cells have architectural or cytological atypia that is inadequate for a diagnosis of follicular neoplasm, suspicious for malignancy or malignant, based upon the 2009 Bethesda system for thyroid cytopathology (Am J Clin Pathol 2009;132:658)
Terminology
  • Also called "Atypia of Undetermined Significance" (AUS) or "Follicular Lesion of Undetermined Significance" (FLUS)
Criteria
  • Nine Categories according to 2009 Bethesda Criteria (Am J Clin Pathol 2009;132:658):
    • Prominent population of follicle cells forming microfollicles with overall sparse cellularity
    • Predominance of Hürthle cells in a sparse cellularity and scant colloid
    • Artifact (air-dried prep, clotting artifact) that hinders interpretation, but atypia still present
    • Moderate or marked cellularity with vast majority being Hürthle cells but clinically has lymphocytic thyroditis or nodular goiter
    • Focal features suggestive of papillary carcinoma, but predominantly benign appearing sample
    • Atypical cyst lining cells
    • Small population of follicle cells with large nuclei and prominent nuclei, suggestive of radioactive iodine or carbimazole treatment or repair due to cystic degeneration or hemorrhage
    • Atypical lymphoid infiltrate not definitely diagnostic for "suspicious of malignancy"
    • Not otherwise specified
Management
  • Risk of malignancy: 5 - 15%
  • Repeat FNA (3 - 6 months) (Cancer 2007;111:508), sooner if worrisome clinical features
  • Repeat FNA usually leads to definitive diagnosis in 75 - 80% (Thyroid 2009;19:1215)
  • Malignancy occurs in 20 - 25% of those with this diagnosis
Sample reports
  • Atypia of undetermined significance
    • Follicular cells, mostly benign appearing, with rare cytologic atypia
    • Comment: a repeat aspirate after an appropriate interval may be helpful if clinically indicated
  • Follicular lesion of undetermined significance
    • The sample consists almost exclusively of Hürthle cells in a sample with moderate cellularity and scant colloid with no apparent increase in lymphoid cells
    • Comment: in a patient with multiple nodules, these findings are consistent with Hürthle cell hyperplasia in multinodular goiter, but a Hürthle cell neoplasm cannot be completely ruled out; clinical correlations are necessary
Cytology images

Scroll to see all images.


Images hosted on other servers:

General:

Architectural atypia



Follicle cells forming microfollicles with overall sparse cellularity:



Blood and air drying artifact:

Atypical follicular cells



Focal features of PTC:

Benign macrofollicles



Atypical cyst lining cells:



Post-radioiodine:

Atypical cells



Atypical lymphoid cells:



Other:

Numerous noncohesive spindle cells